ELBARETGENE PARVEC
UNII M2WG9XP9JN

Substance Identification & Data

This profile provides standardized clinical and technical data for Elbaretgene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M2WG9XP9JN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3059403-37-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
M2WG9XP9JN
CAS Registry Number
3059403-37-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ELBARETGENE PARVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13832
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elbaretgene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELBARETGENE PARVEC

Common Names & Synonyms

ELBARETGENE PARVEC [INN]
RECOMBINANT, NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 8 (RAAV8) VECTOR ENCODING CODON-OPTIMISED HUMAN CYTOCHROME P450 FAMILY 4 SUBFAMILY V MEMBER 2 (CYP4V2) PRECEDED BY A KOZAK SEQUENCE, UNDER CONTROL OF A CAG PROMOTER (CYTOMEGALOVIRUS (CMV) ENHANCER/CHICKEN .BETA.-ACTIN PROMOTER WITH EXON 1 AND INTRON 1/RABBIT .BETA.-GLOBIN SPLICE ACCEPTOR), A WOODCHUCK HEPATITIS VIRUS POST-TRANSCRIPTIONAL REGULATORY ELEMENT (WPRE) AND A SIMIAN VIRUS 40 (SV40) POLYADENYLATION SIGNAL; FLANKED BY ADENO-ASSOCIATED VIRUS 2 (AAV2) INVERTED TERMINAL REPEATS (ITRS)